Phase 2 study of S-888711 in thrombocytopenic patients with chronic liver disease
Latest Information Update: 20 Oct 2022
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 25 Mar 2015 New trial record